John has over 20 years' experience in the pharmaceutical industry with GlaxoSmithKline.

From 2001 to early 2015, John was Director of Global Commercial Strategy in the Metabolic and Cardiovascular therapy areas.

 

John has in-depth experience in new product forecasting, in-line sales forecasting, value proposition development and strategic planning for all aspects of new product development.

 

John received his bachelor’s degree in Mechanical Engineering from the Cooper Union, School of Engineering and holds an MBA from the Harvard Business School.